![]() ![]() ![]() Introduction: A reduced number of trials evaluated the effects of SGLT2 inhibitors on glucose pattern by CGM, but neither compared these effects with other class of antidiabetics. O1 A randomized controlled trial to compare the glycemic effects of dapagliflozin, a sodium glucose cotransporter 2 inhibitor, and gliclazide modified release, a sulphonylurea, assessed by CGMS André Gustavo Daher Vianna, Claudio Silva de Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Kleber Ramos Marques, Emerson Cestari Marino, Josiane Melchioretto Detsch, Claudia Pinheiro Sanches Centro de Diabetes Curitiba, Curitiba, Brazilĭiabetology & Metabolic Syndrome 2019, 11(Suppl 1):O1
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |